Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#2 clBTC clBTC +12.08%
#3 Tutorial Tutorial +6.71%
#4 Palladium Network Palladium Network +6.69%
#5 OpenEden OpenEden +6.37%
#6 EfficientFrontier EfficientFrontier +5.09%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +4.66%
#8 Momentum Momentum +4.55%
#9 Prom Prom +3.88%
#10 Bedrock Bedrock +3.76%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
Classifica tra le azioni #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Prezzo delle azioni
$0.2301
Ultima sincronizzazione: 2026-08-12
Capitalizzazione di mercato
$228.81K
Variazione (1 giorno)
-17.82%
Variazione (1 anno)
95,775.00%
Paese
US
Scambia The Greater Cannabis Company, Inc. (GCAN)

Categoria

Healthcare
Storico del prezzo dell'azione per The Greater Cannabis Company, Inc. (GCAN)
Prezzo di chiusura più alto: $0.31 il 2026-08-01

Prezzo di chiusura più basso: $0.21 il 2018-09-01
Storico del prezzo dell'azione di The Greater Cannabis Company, Inc. dal 2018 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 105.21%
2025 16,126.48%
2024 -47.34%
2023 41.11%
2022 -82.95%
2021 14.35%
2020 -91.59%
2019 -74.42%
2018 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $58.34 59.83%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 $50.11 76.63%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 $186.82 44.08%
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 $62.63 5.00%
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $111.21 54.46%
US